Delivery Share Breakouts : Talbros Automotive Components , Alembic and Others: 10-Jul-2024

Ambalal Sarabhai Enterprise Ltd.,

In the most recent financial analysis for Ambalal Sarabhai Enterprise Ltd.,, key metrics demonstrate a solid performance. The net sales reached ₹406.97 million, with total income amounting to ₹429.99 million. Expenditure was recorded at ₹-417.95 million, resulting in a net profit of ₹3.47 million. EPS figures for continuing operations are ₹0.05. Other notable figures include other income of ₹23.03 million, finance costs of ₹-9.55 million, and employee benefit expenses totaling ₹-72.14 million. Depreciation and amortization expenses were ₹-9.79 million, with current tax at ₹-1.30 million and deferred tax at ₹-3.66 million. The total comprehensive income for the period was ₹3.79 million, and other comprehensive income net of taxes was ₹0.32 million.

The company has a market capitalization of ₹492 crore and a current stock price of ₹64.2. Historically, the stock has fluctuated between ₹77.7 / 34.0. With a Price-to-Earnings (P/E) ratio of 41.8, the stock appears highly valued. The book value per share is ₹17.9, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 7.08% and the Return on Equity (ROE) is 4.22%. The debt-to-equity ratio is very low at 0.34, although the company reports a net cash flow of ₹0.65 crore. The Piotroski score is 4.00, and the Graham Number estimates the intrinsic value of the stock at ₹24.9. The Price-to-Book (P/B) ratio is 3.59, indicating the stock is trading at a premium relative to its book value.

Talbros Automotive Components Ltd.,

In the most recent financial analysis for Talbros Automotive Components Ltd.,, key metrics demonstrate a solid performance. The net sales reached ₹2.00 million, with total income amounting to ₹2.00 million. Expenditure was recorded at ₹-1.00 million, resulting in a net profit of ₹206.15 million. EPS figures for continuing operations are ₹3.34. Other notable figures include other income of ₹48.90 million, finance costs of ₹-33.38 million, and employee benefit expenses totaling ₹-234.48 million. Depreciation and amortization expenses were ₹-78.74 million, with current tax at ₹-60.65 million and deferred tax at ₹2.62 million. The total comprehensive income for the period was ₹402.95 million, and other comprehensive income net of taxes was ₹196.81 million.

Valued at ₹2,073 crore, the company's stock trades at ₹336, with historical highs and lows of ₹396 / 184. The P/E ratio of 24.8 reflects a high stock valuation. The book value is ₹87.0, and the dividend yield is 0.21%. ROCE is at 21.4%, and ROE is 17.2%. The company’s minimal debt-to-equity ratio of 0.18 contrasts with its negative net cash flow of ₹-2.92 crore. The Piotroski score is 6.00, and the Graham Number of ₹189 provides insight into the stock’s valuation. The Price-to-Book (P/B) ratio of 3.86 indicates a premium valuation.

Alembic Pharmaceuticals Limited

In the most recent financial analysis for Alembic Pharmaceuticals Limited, key metrics demonstrate a solid performance. The net sales reached ₹14,755.57 million, with total income amounting to ₹14,787.02 million. Expenditure was recorded at ₹12,655.02 million, resulting in a net profit of ₹1,761.91 million. EPS figures for continuing operations are ₹8.96. Other notable figures include other income of ₹31.45 million, finance costs of ₹126.92 million, and employee benefit expenses totaling ₹3,565.14 million. Depreciation and amortization expenses were ₹686.76 million, with current tax at ₹370.09 million and deferred tax at ₹0.00 million. The total comprehensive income for the period was ₹1,729.72 million, and other comprehensive income net of taxes was ₹-32.19 million.

With a market capitalization of ₹23,371 crore, the company’s stock is currently priced at ₹1,189. The historical trading range of the stock is ₹1,286 / 707. The P/E ratio is remarkably high at 37.1, suggesting a significant valuation. The book value stands at ₹245, and the dividend yield is 0.92%. The Return on Capital Employed (ROCE) is 13.1%, and the Return on Equity (ROE) is 13.3%. The debt-to-equity ratio is very low at 0.11, though the company shows a negative net cash flow of ₹44.7 crore. The Piotroski score is 9.00, with the Graham Number pegged at ₹420. The Price-to-Book (P/B) ratio of 4.85 highlights a premium valuation.

Walchandnagar Industries Limited

The latest financial figures for Walchandnagar Industries Limited indicate a strong performance. The company achieved net sales of ₹791.70 million and total income of ₹1,034.50 million for the quarter. Expenditure was ₹1,051.80 million, resulting in a net profit of ₹-17.30 million. Earnings per Share (EPS) for continuing operations stood at ₹-0.31. The report also shows other income of ₹242.80 million, finance costs of ₹105.80 million, and employee benefit expenses of ₹203.00 million. Depreciation and amortization expenses totaled ₹26.10 million. Current tax expense was ₹0.00 million and deferred tax expense was ₹0.00 million. Total comprehensive income for the period was ₹-10.80 million, with other comprehensive income net of taxes at ₹6.50 million.

The company has a market capitalization of ₹1,856 crore and a current stock price of ₹335. Historically, the stock has fluctuated between ₹382 / 92.9. With a Price-to-Earnings (P/E) ratio of , the stock appears highly valued. The book value per share is ₹65.2, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 1.29% and the Return on Equity (ROE) is -13.4%. The debt-to-equity ratio is very low at 0.67, although the company reports a net cash flow of ₹54.0 crore. The Piotroski score is 6.00, and the Graham Number estimates the intrinsic value of the stock at ₹. The Price-to-Book (P/B) ratio is 5.14, indicating the stock is trading at a premium relative to its book value.